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Abstract
Background: Central nervous system axons lack a robust regenerative response following spinal cord injury (SCI) and 
regeneration is usually abortive. Supraspinal pathways, which are the most commonly studied for their regenerative 
potential, demonstrate a limited regenerative ability. On the other hand, propriospinal (PS) neurons, with axons intrinsic 
to the spinal cord, have shown a greater regenerative response than their supraspinal counterparts, but remain 
relatively understudied in regards to spinal cord injury.
Results: Utilizing laser microdissection, gene-microarray, qRT-PCR, and immunohistochemistry, we focused on the 
intrinsic post-axotomy response of specifically labelled thoracic propriospinal neurons at periods from 3-days to 1-
month following T9 spinal cord injury. We found a strong and early (3-days post injury, p.i) upregulation in the 
expression of genes involved in the immune/inflammatory response that returned towards normal by 1-week p.i. In 
addition, several regeneration associated and cell survival/neuroprotective genes were significantly up-regulated at 
the earliest p.i. period studied. Significant upregulation of several growth factor receptor genes (GFRa1, Ret, Lifr) also 
occurred only during the initial period examined. The expression of a number of pro-apoptotic genes up-regulated at 
3-days p.i. suggest that changes in gene expression after this period may have resulted from analyzing surviving TPS 
neurons after the cell death of the remainder of the axotomized TPS neuronal population.
Conclusions: Taken collectively these data demonstrate that thoracic propriospinal (TPS) neurons mount a very 
dynamic response following low thoracic axotomy that includes a strong regenerative response, but also results in the 
cell death of many axotomized TPS neurons in the first week after spinal cord injury. These data also suggest that the 
immune/inflammatory response may have an important role in mediating the early strong regenerative response, as 
well as the apoptotic response, since expression of all of three classes of gene are up-regulated only during the initial 
period examined, 3-days post-SCI. The up-regulation in the expression of genes for several growth factor receptors 
during the first week post-SCI also suggest that administration of these factors may protect TPS neurons from cell 
death and maintain a regenerative response, but only if given during the early period after injury.
Background
Spinal cord injury (SCI) creates an environment enriched
in factors that inhibit axonal regeneration including
myelin proteins and chondroitin sulfate proteoglycans
that has been extensively reviewed [1-3]. The supraspinal
pathways most often tested after SCI for their regenera-
tive ability (i.e. corticospinal tract; rubrospinal tract),
have limited inherent regenerative abilities, even when
more permissive environments are established at the
injury site [4,5]. One factor related to the limited regener-
ation of supraspinal axons is the long distance between
the site of axotomy and their cell bodies of origin. Previ-
ous studies have demonstrated neurons mount a stronger
regenerative response if axotomy occurs closer to the cell
body [6-8]. This may be why propriospinal (PS) axons,
from neurons intrinsic to the spinal cord, show greater
regenerative ability than supraspinal nerve tracts when
the same experimental strategies are used to increase
regeneration after SCI [9-13].
In concert with supraspinal nerve tracts, PS neurons
play an important role in locomotor function, limb coor-
dination, and postural support [14]. In spite of their
i m p o r t a n c e  i n  s p i n a l  m o t o r  f u n c t i o n ,  a s  w e l l  a s  t h e i r
greater regenerative potential, and potential for post-
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injury axonal plasticity [15,16], PS neurons have been rel-
atively understudied. Preliminary studies from our labo-
ratory show an initial large loss of thoracic PS (TPS)
neurons two weeks following moderate T9-10 spinal con-
tusion injury (25 mm weight drop, NYU Impactor), but
~30% of axotomized TPS neurons remain rostral to this
injury for at least one month, as assessed by prelabeling
these cells from the lumbosacral spinal cord prior to spi-
nal injury [17]. The present investigation is a detailed
analysis of the cellular response of TPS neurons after low
thoracic complete SCI. We paid particular attention to
changes related to their regenerative ability and to early
cell loss, based on the hypothesis that the short distance
from the lesion would ensure a maximal regenerative
response.
Using whole-transcriptome profiling with microarrays,
followed by qRT-PCR and immunohistochemistry for
validation, we found a strong initial inflammatory
response as well as an early regeneration and cell death
response. An up-regulation of several growth factor
receptors, as well as a down-regulation of receptors to
several factors that inhibit axonal growth may indicate
potential therapeutic treatments to protect TPS neurons
from early cell death post-axotomy and to maximize and
sustain the early regenerative response.
Methods
The SUNY Upstate Medical University Committee for
the Humane Use of Animals, following the provisions and
guidelines set forth by the institutional Department of
Laboratory Animal Research and the Association for
Assessment and Accreditation of Laboratory Animal
Care (A.A.A.L.A.C), approved all procedures involving
the use of animals.
Female hooded Long-Evans rats (N = 36, Simonsen;
Santa Clara; CA) approximately 77 days (± 10 days) old
were used in this study. Animals were assigned to various
labeling, injury, and survival time-points (see Table 1 for
group assignments).
Animal Surgeries
Retrograde Labelling of Thoracic Propriospinal (TPS) Neurons
Animals were anesthetized by an intraperitoneal (IP)
injection of a ketamine/xylazine cocktail (0.07 cc/100 g).
Once the animal was areflexic, a laminectomy was per-
formed at the T-13 vertebral level exposing the upper
lumbosacral enlargement. The spinal cord was exposed
using a 26G needle to open the dura. Injections of retro-
grade label (see below) were made using a 5 μl Hamilton
syringe (Hamilton Company; Reno; NV) with a micropi-
pette tip (30 μm inner diameter) glued to the syringe nee-
dle. The syringe was attached to a micrometer injection
apparatus seated in a stereotaxic frame. A total of six 0.30
μl Fluorogold (FG; Biotinum Inc; Hayward; CA; 3% w/v in
dH2O) or Dextran Tetramethyl Rhodamine 3,000 M.W.
(DTMR; Molecular Probes; Eugene; OR; 1% w/v in 1 ×
PBS) injections were made bilaterally centered within the
intermediate gray matter (laminae V - VIII) at the rostral,
middle, and caudal aspects of the laminectomy site. The
needle penetrated through the dorsal surface of the spinal
cord for a distance of 1 mm on either side near the mid-
line, and was then withdrawn 500 μm before beginning
the injection. The injection was made over 5 minutes,
leaving the needle in place for 1 minute prior to retrac-
tion to limit leakage of label.
Spinal Transection
one-week post-retrograde labeling, animals in experi-
mental groups receiving a spinal transection were again
anesthetized with ketamine/xylazine. A laminectomy was
performed at the T9 vertebral level. Once the spinal cord
was exposed a pair of iridectomy scissors (Fine Scientific
Tools; Foster City; CA) was used to transect the cord, and
with a successful transection the rostral and caudal edges
of the cut spinal cord retracted exposing the underlying
vertebrae. Following transection, a probe was scraped
along the inner wall of the vertebral canal through the
lesion site to further ensure a complete lesion. Gelfoam
soaked in 0.9% isotonic saline was used to stop any bleed-
ing.
Spinal Contusion
After appropriate tracer transport time (see Table 1 for
details), animals were anesthetized with an IP injection of
sodium pentobarbital (Nembutal 0.1 cc/100 g). Once
areflexic, a laminectomy was performed at the T9/T10
vertebral level exposing the lower thoracic spinal cord.
The animal was positioned and secured into the frame of
an NYU Impactor by clamping the T8 and T11 spinous
processes, followed by a moderate spinal contusion
injury, dropping a 10 g rod from a height of 25 mm using
the MASCIS protocol [18,19]. Successful injuries were
determined by the Impactor analysis, visual inspection of
the lesion under the surgical microscope, and complete
acute loss of hindlimb responses after recovery from
anesthesia.
Post-Operative Care
Following each surgical labeling or SCI procedure, ani-
mals were sutured using 3.0 silk to close the musculature,
and 3.0 Nylon to close the skin; external sutures were
removed after the first week post-operatively. All spinal
injured animals received twice daily bladder expression
until the micturition reflex returned, and injections of
Cefazolin (Sandoz Inc; Princeton; NJ; 0.03 cc, SQ) were
given twice daily for the first week following spinal injury
to prevent urinary tract infections, or when infections
occurred. Buprenorphine hydrochloride (Buprenex
injectable; Ben Venue Laboratories Inc; Bedford; OH;
0.03 cc SQ) was given twice daily for the first 48 hrs post-Siebert et al. BMC Neuroscience 2010, 11:69
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operatively for pain management. All post-operative ani-
mals had ad libitum access to both food and water.
Histology
FG Tissue
Following the assigned post-operative recovery time, ani-
mals were euthanized by an IP injection of sodium pento-
barbital (Fatal Plus, 0.5 cc) and then decapitated. The mid
thoracic spinal cord, T5-T8, was rapidly dissected,
embedded in O.C.T compound (Tissue Tek® embedding
medium), and rapidly frozen on dry ice. Tissue samples
were stored at -80°C until processing. Tissue sections
were cut transversely at 16 μm using a cryostat and
mounted on glass Superfrost Plus slides (Fisher; Pitts-
burgh; PA) or poly-ethylennaphtalae (PEN) foil slides
(Leica; Wetzar; Germany) and maintained at -20°C dur-
ing the sectioning process. Slides were stored at -80°C
until laser microdissection (LMD).
DTMR Tissue
Animals were euthanized by an injection of sodium pen-
tobarbital (Fatal Plus, 0.5 cc), and transcardially perfused
with 500 ml 0.1 M 1 × PBS (pH 7.4) followed by 500 ml
4% paraformaldehyde (pH 7.4). Spinal cords were post-
fixed in 4% paraformaldehyde for 24 hours followed by
cryoprotection in 20% sucrose for a minimum of 24
hours. Tissue samples were embedded in O.C.T com-
pound (Tissue Tek® embedding medium) and frozen on
dry ice. Tissue samples were stored at -20°C throughout
sectioning and storage. Cryostat sections were cut in the
transverse plane at a thickness of 20 μm, and slides con-
taining tissue sections were stored at -20°C until further
processing.
Immunohistochemistry
Retrogradely labelled DTMR-TPS neurons were probed
immunohistochemically for various neurotrophic recep-
tors (Trk A, B, C, GFRα1; 1:100, or Ret; 1:300; Santa-
Cruz; Santa-Cruz; CA), a marker of cell stress (HSP-27
"Hsbp1"; Rabbit IgG; 1:200; Assay Designs|Stressgen;
Ann Arbor; MI), a protein involved in axon regeneration
(GAP-43;1:250; Millipore; Bellerica; MA), and a marker
of cell death (activated caspase 3;1:250; Sigma-Aldrich;
St. Louis; MO). All retrogradely labeled tissue was incu-
bated in primary antibodies overnight at 4°C. Secondary
labeling of GFRα1 and Ret was bioamplified, and visual-
ized using strepavidin-FITC conjugate 1:300 in avidin
buffer. Secondary antibody detection of all other primary
antibodies used either a goat anti-rabbit or mouse - FITC
conjugate (1:50; Zymed laboratories; San Francisco; CA)
or goat anti-rabbit Marina Blue (1:300; Invitrogen; Carls-
ba d ;  CA ) .  A l l  s i d es  w e r e  c o v e r s l i p ped  wi t h  v ec tas h e i l d
(Vector Labs Inc; Burlingame; CA).
Microarray Techniques
Laser Microdissection
Tissue was mounted on poly-ethylennaphtalae (PEN) foil
slides (Leica, Wetzar; Germany) that were maintained on
dry ice until laser microdissection. Once a slide was
removed from the dry ice, neurons were dissected over a
period of 10 minutes. Slides were positioned on the stage
of a Leica AS LMD microscope (Leica Microsystems;
Table 1: Animal and Experimental Treatment Groups
Animal Group N Label Injury Type Survival Post Injury Total Survival Time 
Post Label
Group Comparison
1 4 FG No --- --- 10 Days 1 to 4
2 4 FG No --- --- 3 Weeks 1 to 5
3 4 FG No --- --- 5 Weeks 2 to 6
4 4 FG Yes TXN 3 Days 10 Days 3 to 7
5 4 FG Yes TXN 1 Week 2 Weeks
6 4 FG Yes TXN 2 Weeks 3 Weeks
7 4 FG Yes TXN 5 Weeks 5 Weeks
8 4 DTMR Yes CON 1 Week 2 Weeks 8 to 9
9 4 DTMR No --- --- 2 weeks 8 to 5
Female Long-Evans rat were divided among 9 groups. Then using the indicated tracer, Fluorogold (FG) or Dextran Tetramethyl Rhodamine 
(DTMR), TPS neurons were prelabeled by a series of bilateral injections into the upper lumbrosacral enlargement. Following 1-week tracer 
transport time, animals in groups 4-8 were subjected to either a T9 complete spinal transection (TXN) or moderate spinal contusion injury (25 
mm weight drop, NYU Impactor; CON). Animals were then allowed to recover for different periods post-injury as indicated. N used in analysis 
indicates the number of animals that were used in the data analysis part of this study. (*) Group 6 only has an N of 2 due to 1 animal failing to 
pass the microarray's internal quality control, and the loss of 1 animal to freezing artifact during histological processing. (*) Group 7 only has 
an N of 2 due to premature animal mortality. The final column of this table indicates the time point comparisons that were made for both the 
gene and PCR validation studies conducted during this study.Siebert et al. BMC Neuroscience 2010, 11:69
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Bannockburn; IL). Retrogradely labeled FG-TPS cells
were visualized under the UV filter using the 10 × objec-
tive (Figure 1B). Using the microscope's computer soft-
ware, FG labeled cells located within the intermediate
gray matter (laminae V, VII, VIII, and around the central
canal, lamina X; Figure 1A,B) were individually dissected
(Figure 1C); a minimum of 200 FG labeled neurons were
collected from each animal.
RNA Purification & Amplification
Dissected neurons were collected directly into a PCR
tube cap containing 30 μl RLT lysis buffer (Qiagen; Valen-
cia; CA) with 1% β-marcaptoethanol (Sigma Aldrich; St.
Louis; MO). RNA was t hen purified using t he RNeasy
Mini kit (Qiagen; Valencia; CA), eluted in 30 μl nuclease
free water , and concentrated down to 10 μl by vacuum
centrifugation. Total RNA concentration was determined
by loading 1 μl of concentrated sample onto an RNA 6000
Pico Chip (Agilent Technologies; Santa Clara; CA).
Acceptable RNA samples (those with only minimal or no
evidence of degradation) were amplified and labeled
using the Ovation™ Biotin RNA Amplification and Label-
ing System (NuGen; San Carlos; CA), producing a 10,000
fold amplification of the mRNA. Using the basic 3' Ribo-
SPIA™ (NuGen; San Carlos; CA), the mRNA was then
used to produce an enriched anti-sense cDNA probe for
hybridization to the Rat Gene 1.0 ST Array (Affymetrix;
Santa Clara; CA).
Microarray Hybridization
All microarray processing was performed using standard
hybridization, washing, staining, and scanning protocols
in the SUNY Microarray Core lab at Upstate Medical
University. Following scanning, the raw array images
were converted to .CEL file images for downstream anal-
ysis. All the array data for this study have been deposited
at the NCBI Gene Ascension Omnibus (GSE20907, http:/
/www.ncbi.nlm.nih.gov/geo/query/
acc.cgi?acc=GSE20907)
RT-PCR
The reverse transcriptase reaction to convert the RNA
probes into first strand cDNA for PCR was carried out
using the RT2 First Strand Kit (SA Biosciences; Frederick;
MD) following the manufacturer's directions and using
the supplied reagents for each RNA sample. PCR was
performed using the RT2 SYBR Green qPCR Master Mix
and RT2 Profiler™ PCR Array for Rat Neurotrophins and
Receptors (SA Biosciences; Frederick; MD) following the
manufacturers directions and using the supplied
reagents. PCR plates were run on a Roche 480 LightCy-
cler.
Imaging and Data Analysis
Fluorescent Microscopy
All images were taken on a Zeiss Axio Imager A.1 micro-
scope (Carl Zeiss, Germany). DTMR labeling was viewed
under a CY3 filter, while the immunohistochemistry was
viewed under either a FITC or DAPI filter. All images
were captured using a SPOT RT slider camera, model
2.3.1 (Diagnostic Instruments; Sterling heights; MI). All
digitized images where processed in the Spot™ Advanced
software (v. 3.3.4 for Macintosh, Diagnostic Instruments
Inc.), using the RGB color histogram tool to adjust both
the image brightness and contrast. No other manipula-
tions were made to these images.
Microarray
Quantile-normalized expression values were obtained for
all genes using RMA normalization of the .CEL file data
in GeneSpring GX (Agilent Technologies) and selected
Figure 1 Laser microdissection of thoracic propriospinal (TPS) 
neurons for microarray analysis. A, TPS neurons selected for micro-
dissection were located within laminae V, VII, VIII, and X of the thoracic 
spinal cord. B, Thoracic propriospinal (TPS) neurons retrogradely la-
beled by fluorogold (FG) injections into the lumbosacral enlargement 
are shown at 10 × magnification under an ultraviolet filter. The white 
dashed line marks the boundary of the white and gray matter, while 
the yellow dashed line outlines the laminae area from which neurons 
were collected. C, Region from which a FG labeled TPS had been indi-
vidually laser microdissected yielding a relatively pure TPS neuron RNA 
message. Figure 1a was adapted from: The Spinal Cord (Watson C, Pax-
inos G, Kayalioglu G ed.) p 270, New York, Academic PressSiebert et al. BMC Neuroscience 2010, 11:69
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data formatted for import into Microarray Experiment
Viewer 4.2 (MEV 4.2) [20]. Significant changes in expres-
sion of single genes were detected using a 2-way ANOVA
to compare the effects of treatment across four time-
points post surgery. The resulting P values from the main
effect ANOVA were corrected for multiple testing using
the Benjamini-Hochberg False Discovery Rate (FDR)
algorithm.
Because the study design included assessments of
expression changes at four discrete time-points post-SCI,
we also chose to provide an overview of the genes with
the most robust changes at any one or more particular
time-points, whether or not that change generalized
across all time-points. Thus, we compiled a table that
contained lists of the genes with the largest significant
increases in expression and the largest significant
decreases in expression at one or more of the four time-
points (see Additional File 1). From these lists, we
selected the 20 genes with the largest increases and 20
genes with the largest decreases for hierarchical cluster-
ing and heat map visualization.
In addition to the hypothesis-free analysis of genome-
wide expression data, we also determined whether there
were significant expression changes in three specific cus-
tom-designed gene networks that we hypothesized would
be critically involved in the response to injury. These net-
works included: (1) Regeneration Associated Genes and
Cell-Survival and Neuroprotection Genes (RAG and
CsNp Genes); (2) Surface Receptor and Growth Factor
(GF) Genes; and (3) Apoptosis Genes. Complete lists of
the genes in each of these networks are provided in the
Additional Data section. Each network was compiled
from only genes with expression values exceeding the
lowest 15 percentile of all genes on the array. Within each
network, significance was determined by permutation of
the 2-factor (treatment × time) ANOVA matrix, with a P
value cutoff of 0.01 based on 1000 permutations within
MEV 4.2.
To determine the evidence for enrichment of signifi-
cantly changed genes in specific biological pathways or
gene networks, Ingenuity Pathway Assist (IPA) software
(Ingenuity) was utilized. Data s e ts  f o r  e a c h  t i m e -po i n t
were uploaded to IPA consisting of all the genes changed
at the Benjamini-Hochberg FDR-corrected P value of
0.05 or less. These data sets were then filtered using IPA
software to include only those genes which were anno-
tated as expressed in any nervous tissue or immune cell as
well as changed in expression by at least +/- 0.25 on a log2
scale. The top Bio Functions results were complied from
each of the IPA analyses (see Additional Data section) for
all gene networks containing 5 or more genes. Corrected
significance values for each gene that mapped to these
Bio Function networks were generated by IPA. Selected
g e n e  n e t w o r k s  t h a t  s h o w e d  u p  i n  m u l t i p l e  t i m e - p o i n t
analyses were used to generate biological interaction net-
work/pathway diagrams in IPA for comparative purposes
(see Additional Data).
qRT-PCR
The average Cp value for each gene of interest (GOI),
both in non-injured controls and spinally transected ani-
mals, was calculated and then compared to a given set of
reference genes included on the plate to give us the ΔCp
value. For each GOI the ΔCp value of the spinally
transected group value was subtracted from the mean
ΔCp value of the control group to yield the ΔΔCp, from
which the directional and fold change in our GOI were
determined. PCR validation of our GOI was performed
by plotting the log2 difference of the lesion versus control
groups for both the PCR data and microarray data, and
subsequently determining the Pearson correlation
between the expression changes determined using these
two approaches.
Results
Gene-Microarray analysis of the TPS intrinsic response to 
axotomy
Hypothesis -free single gene analysis
We first initiated a genome wide, hypothesis free analysis
to examine the overall response of TPS neurons to axo-
tomy following a low thoracic spinal transection. The
genes with significant main effects of SCI were used for
subsequent gene network analyses. In addition, we com-
piled lists of the genes with the most robust increases or
decreases in expression at one or more of the four time-
points (see Additional File 1). Out of these lists, the
expression profiles of the top 20 genes both up and down
regulated are illustrated in Figure 2 following hierarchical
clustering, and listed in Table 2.
The pattern of gene expression (Figure 2) illustrates
that the most significant change occurs 3-days post injury
(p.i.; Post 1.1-1.4), and begins to wane by 1-week p.i. (Post
2.1 - 2.4). At the 1-month time-point (Post 4.1 and 4.2)
the expression levels for most genes appear to return near
the level of uninjured control animals. Initially, genes
exhibiting a significant down-regulation appear to be
mainly involved with different aspects of neuronal cell
biology (Table 3), with no one aspect of cell biology being
heavily represented. The genes exhibiting the strongest
up-regulation are primarily involved with the immune/
inflammatory response (Cxcl13, Ccnb1, Hcst, Fyb, Lcn2,
Itgam, Fgcr2b, Cybb, and Clec4a3; Table 2), or cell main-
tenance/survival/stress (Ms4a6b, Hspb1, Ccnb1, Atf3,
Emr1, Plk1, Diap3, Cp, and Casc5; Table 2).
Hypothesis-based gene network analyses
We also determined which biological pathways or gene
networks are most consistently affected in TPS neurons
following spinal transection using Ingenuity Pathway
Assist (IPA) software (Ingenuity) to map those genes withSiebert et al. BMC Neuroscience 2010, 11:69
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Figure 2 Genetic expression profiles for the top 20 genes up-regulated and down-regulated following spinal transection. The expression 
profiles illustrate the normalized log2 expression values with low expression values being represented by green and high expression in red. The 20 
genes exhibiting the greatest up-or down- regulation were determined by using a 2-way ANOVA comparing the effects of treatment across post-
operative survival points. The resulting P values from the main effect ANOVA were Benjamini-Hochberg corrected for multiple testing. Further inves-
tigation of the top 20-upregulated genes revealed a majority of them were either involved or associated with immune function and inflammation, or 
in cell maintenance and survival (Table 2.2). The top 20 genes down-regulated were mainly involved in different aspects of neuron cell biology. As 
illustrated in this expression profile, the maximal response (up- or down-regulation) is found during the first, three day, post-injury interval (Post 1.1-
1.4). As time progresses, gene expression levels begin to wane (Post 2.1-2.4) returning to levels near to that seen in non-injured control animals by 1-
month post-injury (Post 4.1-4.2). This overall analysis of the TPS response to a low thoracic injury suggests that the immune and inflammatory response 
plays a major role in the early post-injury response of TPS neurons.Siebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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significant main effects across all time-points. Three days
p.i. 39 biological pathways/gene networks containing 838
genes are significantly affected with the top 6 being: anti-
gen presentation (52 genes), inflammatory response (52
genes), immune cell tracking (52 genes), hematological
system development and function (52 genes), cell to cell
signaling and interaction (52 genes), and cell-mediated
immune response (44 genes) (See Additional File 2) the
same gene can be involved in more than one related path-
way/network). By one week p.i, there is a much more
focused response with only 3 pathways/gene networks
significantly affected containing many fewer genes (32
genes) than at 3-days p.i.. There is also a large shift from
immune related genes to genes involved in nervous sys-
tem development (18 genes) cellular growth and prolifer-
ation (9 genes), and neurological disease (5 genes). Only 5
of 27 significantly changed genes in the nervous system
development and function category at 3-days p.i. are
among those changed 1-week p.i.. Similarly only 1 of the
16 genes changed in the cellular growth and proliferation
category at 3-days p.i. and 1 of 30 genes changed in the
neurological disease category are among the genes
changed at 1-week p.i. in these categories. The gene in
these later two categories is Casp3.
By two weeks p.i. there was a significantly expanded
response with 12 gene networks comprised of 70 genes
being affected according to the IPA analysis. The top 3
pathways/networks involved are hematological system
development and function (14 genes), cellular movement
(7 genes), and inflammatory response (7 genes). Only 5 of
the 52 genes changed in the hematological development
and function at 3-days p.i. are among the 14 genes signifi-
Table 2: Top 20 Genes Up-regulated Following Injury
Probe ID Gene Symbol Gene Title Max Log2 
Δ
Known/Presumed 
Function *
10775731 Cxcl13 Chemokine (C-X-C motif) ligand 13 2.88 Immune
10728924 Ms4a6b Membrane-spanning 4-domains, subfamily A, member 6B 2.57 Cell Signaling
10761128 Hspb1 Heat shock protein 27 2.50 Cell Survival
10821016 Ccnb1 Cyclin 1B 2.43 Cell Cycle
10779673 Lgals3 Lectin, galactose binding, soluble 3 2.33 Immune
10804463 Lox Lysyl oxidase 2.32 ECM Modification
10770710 Atf3 Activating transcription factor 3 2.26 Transcription
10720565 Hcst Hematopoietic cell signal transducer 2.22 Immune
10931222 Emr1 EGF-like module contaning, mucin-like, hormone 
receptor-like sequence 1
2.06 Cell-Cell Interaction
10710627 Plk1 Polo-like kinase 1 2.02 Cell Cycle
10813392 Fyb FYN binding protein 2.00 Immune
10785479 Diaph3 Similat to Protein diaphanous homolog 3 1.99 Actin-Cytoskeletal
10865329 Apobec1 Apolipoprotein B mRNA editing enzyme, catalytic 
polypeptide 1
1.98 Transcription 
Modification
10844331 Lcn2 Lipocalin 2 1.97 Inflammatory
10711268 Itgam Integrin alpha M 1.95 Immune
10814430 Cp Ceruloplasmin 1.93 Development and 
Homeostasis
10769771 Fcgr2b Fe fragment of IgG, low affinity Ilb, receptor 1.89 Immune
10936899 Cybb Cytochrome b-245, beta polypeptide 1.85 Immune
10838733 Casc5 Similar to cancer susceptibility candidate 5 1.83 Kinetochore 
Formation
10858559 Clec4a3 C-type lectin domain family 4, member a3 1.82 Immune
Top 20 TPS neuron genes found to be up-regulated following a T9 complete transection. Examination of the genes found to be up-regulated 
revealed a majority of them to be involved with either the inflammatory or immune response. This list has the genes ranked according to their 
log2 change, and has been edited from the overall master list (Supplementary Data, Table S1) to exclude non-coding RNA sequences. (*) 
Known/presumed functions were obtained from the Crown Human Genome Center & Weizmann Institute of Science website GeneCards® 
which can be accessed at http://www.genecards.org/index.shtmlSiebert et al. BMC Neuroscience 2010, 11:69
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cantly changed in this category at 2-weeks. Similarly only
2 of 32 genes significantly changed at 3-days p.i. in the
cellular movement category are among the 7 genes
changed at 2-weeks p.i.. Only 1 of the 52 genes signifi-
cantly changed in the inflammatory response category at
3-days p.i. is among the 7 genes changed in this category
at 2-weeks p.i..
At 1 month p.i., 234 genes involved in 34 different gene
pathways/networks were significantly changed. The top
three networks are nervous system development and
function (14 genes), neurological disease (10 genes), and
cell death (9 genes). Again, few of the 14 genes signifi-
cantly changed in the nervous system development and
function category at 1-month p.i. are also changed at 3-
days (4 of 27), at 1-week (3 of 12), or at 2-weeks p.i. (1 of
6), and only Atf3 is changed at all the time-points other
than 1-week p.i.. Many of the significantly changed genes
in the other two categories at 2-weeks p.i. are found in
both categories at this survival time since they overlap in
function. However few of these genes were significantly
changed at earlier survival times. 17 genes are also signif-
icantly changed at 1-month p.i. in the hematological
development and function category compared to control
expression level. Again, only 1 of 52 genes in this category
at 3-days p.i. is also changed at 1-month p.i.
IPA Biological Pathway/Network Analysis
Gene networks expressed commonly at all four post-
injury time-points (inflammatory response, cell death,
nervous system development and function, neurological
disease, and cell growth and proliferation) were further
explored by composing functional biological network/
pathway analysis using IPA software (See Additional
Files, 3, 4, 5, 6, 7 respectively). These pathways allowed us
to observe how each gene in a pathway interacts with one
Table 3: Top 20 Genes Down-Regulated Following Injury
Probe ID Gene Symbol Gene Title Max Log2 Δ Known/Presumed Function *
10803692 Nrep Neuronal regeneration related protein -1.70 Nerve Outgrowth
10857916 Slc6a11 Solute carrier family 6 (neurtransmitter 
transporter GABA), member 11
-1.40 Neurotransmitter Uptake
10888931 Abhd1 Abhydrolase domain containing 1 -1.19 Multiple Enzymatic
10862194 LOC679835 Similar to Anionic trypsin II precursor gene -1.18 Uncharacterized
10722918 Rlbp1 Retinaldehyde binding protein 1 -1.14 Visual Cycle
10825100 Car14 Carbonic Anhydrase 14 -1.12 Homeostasis
10905284 Tst Thiosulfate sulfurtransferase -1.00 Fe-S Complex Formation
10872473 Fabp3 Fatty acid binding protein 3, muscle and heart -0.89 Fatty Acid Transport
10765740 Kcnj10 Potassium inwardly-rectifying channel, 
subfamily J, member 10
-0.86 Voltage Gates
10742645 Slc22a5 Solute carrier family 22 (organic cation/
carnitine transporter), member 5
-0.83 Carnitine Transporter
10893412 Olr1063 Olfactory receptor 1063 -0.83 Uncharacterized
10782144 Clybl Citrate lyase beta like -0.82 Citrate Lyase Activity
10906608 Slc38a2 Solute carrier family 38, member 2 -0.81 Amino Acid Transporter
10706134 Slc7a10 Solute carrier family 7 (neutral amino acid 
transporter, y+ system), member
-0.80 Glutamatergic 
Neurotransmitter Modulation
10805605 Dok6 Docking protein 6 -0.80 Neurite Outgrowth
10896666 RGD1311362 Similar to hypothetical protein FLJ10204 -0.79 Uncharacterized
10822735 Pex51 Peroxisomal biogenesis factor 5-like -0.78 Peroxisomal Targeting
10785773 Spry2 sprouty homolog 2 -0.77 FGF Antagonist
10721796 Lin7b Lin-7 homolog b -0.72 Channel and Receptor 
Localization
10878210 Kank4 KN motif and ankyrin repeated domains 4 -0.72 Actin Stress Fiber Formation
Top 20 down-regulated genes encompass broad functions of cell biology with no one specific function being heavily represented. This list 
has the genes ranked according to their log2 change, and has been edited from the overall master list (Supplementary Data, Table S1) to 
exclude non-coding RNA sequences. (*) Known/presumed functions were obtained from the Crown Human Genome Center & Weizmann 
Institute of Science website GeneCards® which can be accessed at http://www.genecards.org/index.shtmlSiebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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another, and how, over time, the expression of these
genes and the sub-cellular localization of each of the mol-
ecules changes. For example, the specific gene network
illustrated in Figure 3 shows how genes regulating cell
death interact with each other, and how their expression
(using the same color scale as the expression profile)
changes from 3-days p.i. (Figure 3A) to 1-month p.i. (Fig-
ure 3B; for complete time-point comparison see Addi-
tional File 4). This specific gene network illustrates that 3-
days following injury, brain derived neurotrophic factor
(BDNF) is down-regulated, while the pro-apoptotic gene
caspase3 (Casp3) is upregulated. These two genes exhibit
an inverse relationship with BDNF increasing in expres-
sion and Casp3 decreasing in expression 1-month p.i..
This pathway also illustrates the interactions of Casp3
with protein kinase C delta, (Prkcd), which has been
demonstrated to be involved with apoptosis, and with
ataxia telangiectasia mutated (Atm), thought to be acti-
vated upon signaling of apoptotic stresses.
Custom-designed gene network analysis
In addition to an undirected (i.e. hypothesis free) evalua-
tion of the top changed genes and biological pathways,
three custom-designed gene lists were generated to test
whether these genes were specifically affected by axo-
tomy/spinal injury; regeneration associated/cell stress
and neuroprotection genes, growth factor genes, and
apoptosis-related genes (see below). Once the gene lists
were run through a 2-way ANOVA (see below) we
observed a significant change in expression in only 29 out
of a total 679 genes in three groups of interest (regenera-
tion/survival, growth factors/receptors and apoptosis),
the greatest percentage were in the RAGs/CsNp gene list.
We determined if there was statistical evidence for over-
representation of significantly changed genes in these
groups based on a hypergeometric P value (equivalent to
a 1-sided Fischer's exact test). For the entire set of 24,008
permuted genes examined, only 969 were changed at the
.01 alpha level using our 2 way ANOVA (4.0% of the total
genes) as described in the Materials and Methods. This
compares to 14 significantly changed RAG/CsNp genes
out of 84 tested (16.7%), 8 significantly changed growth
factor genes out of 214 tested (3.7%), and 7 significantly
changed apoptosis genes out of 381 tested (1.8%). This
hypergeometric analysis indicates that the 4.1 fold greater
enrichment in the RAG/CsNp genes was highly signifi-
cant (p = 0.000015) whereas there was no overall change
in growth factor receptor genes (-1.1 fold, p = .42) and
significantly fewer genes were found in the apoptosis
gene group than expected by chance alone (-2.2 fold, p =
.02). The under-representation of apoptosis genes indi-
cates that only a small number of these genes is affected
by spinal injury, all of which were pro-apoptosis (see
Figure 3 Ingenuity Pathway Assist (IPA) analysis of significant 
genes involved in cell death. Data sets for each time point were up-
loaded to IPA that consisted of all the genes changed at the Benjamini-
Hochberg FDR-corrected P value of 0.05 or less. These data sets were 
then filtered using IPA software (See Materials and Methods). IPA bio-
logical/gene network analysis indicates the interaction of groups of 
genes with one another and how their expression decreases (in green) 
or increases (in red) over time. In addition to the visualization of the 
gene interactions, IPA analysis shows the sub-cellular localization of 
each of the molecules. See text for details. For conventions and sym-
bols, refer to Ingenuity website legend description https://analysis.in-
genuity.com/pa/info/help/help.htm#legend.htm.Siebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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below). In fact, this finding was also indicated by the IPA
analysis (see Figure 3, Additional File 4).
Thoracic propriospinal neurons upregulate both 
regeneration associated and neuroprotective survival 
genes following a low thoracic axotomy
Our list of regeneration associated genes (RAGs) and cell
survival and neuroprotection (CsNp) genes was compiled
using the query search available on the Affymetrix
NetAffx website http://affymetrix.com as well as genes
selected from the axonal regeneration and cell survival/
neuroprotection literature. We analyzed the response of
84 genes of interest (GOI; see Additional File 8). GOI that
exhibited significant changes in expression were selected
using a two-factor ANOVA analysis (comparing the effect
of treatment, spinal transection vs. control, and post-
injury survival time) with significance set at the p ≤ 0.01
level based on 1000 permutations.
Fourteen of the 84 GOI exhibited a significant change
in expression for at least one out of the four time-point
comparisons (3-days, 1-week, 2-weeks, and 1-month p.i.).
Eleven of the 14 genes (Table 4; Adycap1, Crem, Sox11,
Gap43, Atf3, Stat3, Cd44, Actb, Ctsb, Tubb3, and Jun)
were involved with the process of regeneration, while the
other 3 genes (Gadd45a, Hspb1, and Tspo) were mainly
involved with cell survival and neuroprotection, although
Hspb1 also has been associated with axonal regeneration
[21]. All 14 genes exhibited a strong up-regulation in
expression 3-days post injury (Figure 4A; Post 1.1 - 1.4)
that was diminished by 1-week post injury (Post 2.1 - 2.4).
Furthermore when the change in gene expression 1-week
p.i. was compared to the expression level of the appropri-
ate control, no significant (p < 0.01) change was detected.
However, despite the lack of statistical significance in the
changes of gene expression, the array data reveal that the
levels of expression in the injured neurons remain ele-
vated above those observed in controls throughout the
later p.i. periods for many of the RAG and CsNp genes.
Thoracic Propriospinal Neurons up-regulate several 
neurotrophic receptors and down-regulate several 
receptors inhibitory to axonal growth
The GOI (gene of interest) list that was complied for sur-
face receptors and neurotrophic agents used the query
search available on the Affymetrix NetAffx website. This
GOI list also contained genes for growth factors and
extracellular matrix (ECM) molecules. The final com-
piled GOI list contained a total of 214 genes (see Addi-
tional File 9) and was analyzed using the 2-factor
ANOVA to determine which genes demonstrated a sig-
nificant change in expression. Eight of the 214 genes
demonstrated a significant change in expression follow-
ing injury (Table 5). Five of the 8 genes were up-regulated
(Figure 4B); 4 are surface receptor genes (Lifr, Ncam1,
Gfra1, Ret) that can bind potent neurotrophic or growth
promoting ligands i.e., glial cell-line derived neurotrophic
factor (GDNF) or leukemia inhibitory factor (LIF). GDNF
and LIF have been shown to promote neuron survival
and/or axonal sprouting/regeneration [22,23]. The fifth
gene is for a potent growth factor (Igf1) associated with
axonal regeneration [2,23,24]. Three genes exhibited a
significant down-regulation following axotomy: Fgf9,
w h i c h  i s  c o m m o n l y  a s s o c i a t e d  w i t h  n e r v o u s  s y s t e m
development [25]; Unc5a, involved with mediating repul-
sive axonal guidance cues; and Lingo1, which negatively
regulates the process of myelination [26-28]. Lingo1 is
also a member of the surface receptor complex that medi-
ates the inhibitory cues mediated by myelin proteins, hin-
dering the process of axonal regeneration [29]. The
surface receptor expression profiles (Figure 4B) for these
genes also exhibit a pattern of expression similar to what
was observed in the RAG and CsNp genes (Figure 3A).
All 8 genes showed a strong change in expression 3-days
p.i. (Post 1.1-1.4) which started to wane 1-week p.i. (Post
2.1-2.4), and eventually approached the expression levels
found in controls by one month p.i. (Post 4.1-4.2).
Thoracic Propriospinal Neurons upregulate many pro-
apoptotic genes following low thoracic axotomy
Using the Affymetrix website, a query search for pro-,
anti-, and apoptosis-related genes was conducted result-
ing in a compiled list of 381 genes (see Additional File 10).
Following analysis using 2-factor ANOVA, only 7 genes
(Table 6) of the 381 complied exhibited a significant (p ≤
0.01) change in expression following transection injury.
However, 6 of the 7 genes were up-regulated, while only 1
gene was down-regulated following axotomy (Figure 4C).
The genes up-regulated following injury are all pro-apop-
totic (See Table 6 for gene references). These genes either
inhibit cell growth inducing apoptosis, Gadd 45γ; activate
the caspase cascade resulting in apoptosis, Casp3; accel-
erate cellular apoptosis by antagonizing the Bcl2 apop-
totic repressor, Bax; promote apoptosis via activation of
caspase 9, Pycard; or have been documented to be pro-
apoptotic or indicative of apoptosis, Bard1 and Dap. The
one down-regulated gene, also pro-apoptotic, was apop-
tosis-inducing factor, Siva1.
The expression pattern of the apoptotic genes again fol-
lowed the overall pattern for the other specific GOI
described above: i.e. expression was highly up- or down-
regulated 3-days post axotomy, but diminished 1-week
post axotomy returning to levels similar to those found in
the control animals, in most cases by the second week
post-SCI. The IPA analysis of the cell death network
described above also shows some of the details of the
apoptotic response that were described earlier (see Figure
3, Additional Files 2 and 4).Siebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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Validation of the gene expression array using qRT-PCR
For validation of the microarray data, we selected the SA
Biosciences Rat Neurotrophin PCR Array (see Materials
and Methods). This array was chosen because it con-
tained pre-validated primer sets for three reference genes
(Rplp1, Rpl13a, and Ldha) that were unchanged in our
array data, six genes that showed a Benjamini-Hochberg
corrected significant effect of treatment (Actb, Hspb1,
Gfra1, Fgf9, Lifr, and Stat3), as well as several other neu-
rotrophin-related genes that showed a nominally signifi-
cant effect of treatment (e.g., Gfra2, Ngfrap1, and Npy)
that did not survive FDR correction (see Methods sec-
tion). The PCR array results confirmed the significant
changes in expression seen for the six genes with signifi-
cant effects of treatment in the microarray analysis, as
well as for three genes with nominally significant treat-
ment effects.
For each of the nine genes listed above we next sought
to make direct comparisons at each time-point between
the microarray and PCR array findings. This was accom-
plished by compiling the log2 differences in expression
that were determined by both techniques, calculating a
Pearson correlation between these values, and testing for
significant treatment effects at each time-point in both
data sets with a student's t test (Figure 5). In general, we
observed relatively strong correlation between the
changes in gene expression observed with both tech-
niques (Figure 5F). When the microarray and PCR array
data for the top three correlated genes were plotted (Fig-
ure 5C-E), the observed expression patterns were highly
similar confirming the results of the correlation analysis
(Figure 5F).
As summarized in Figure 5G, the microarray and PCR
array data corroborate each other. The 9 genes examined
showed a significant change in expression 3-days post
axotomy. Four of these genes (Actb, Fgf9, Gfra1, Hspb1)
demonstrated both a significant change in expression and
a correlated expression trend in both arrays, while the
remaining 5 genes (Gfra2, Ngfrap1, Npy, Lifr, Stat3)
showed a significant change in expression in either the
PCR array or microarray but still demonstrated a corre-
lated mean relative expression trend. At one week post-
axotomy, many of the significant changes in expression
were lost according to PCR array analysis, with only
Hspb1 and Gfra2 still showing a significant change in
expression, similar to what was observed in the microar-
ray data.
Only at one point in our validation comparisons did we
find a discrepancy in the PCR and microarray data, and
that was the expression of Stat3 at 2-weeks post axotomy.
This discrepancy could have been due to the fact that the
PCR conditions for Stat3 were not optimal (only half of
the reactions yielded Cp values) and/or the expression
level of Stat3 was so low that it was not detected in some
Table 4: Specific Regeneration Associated and Neuroprotective Genes of Interest Exhibiting Significant Change in 
Expression Post-Injury
Gene Name Symbol(s) Reference
Actin, beta Actb [76]
Adenylate cyclase activating polypeptide 1 Adcyap1, Pacap [77,78]
Activating transcription factor 3 Atf3 [8,79-82]
CD44 Molecule Cd44 [23]
cAMP response element modulation Crem, Icer [83]
Cathepsin B Ctsb [84]
Growth arrest and DNA-damage-inducible 45 alpha Gadd45a [85]
Growth-associated protein 43 Gap43 [8,86-88]
Heat shock 27 kDa protein Hspb1 [79,82,89-91]
SRY-related HMG-box gene 11 Jun [8,23,92,93]
Jun oncogene Sox11 [83,94]
Signal transducer and activator of transcription 3 Stat3 [23,93]
Translocator protein (18 kDa) Tspo, Bzrp [95,96]
Tubulin, beta 3 Tubb3, Tuj1 [97]
Specific genes from our complied lists of genes of interest (GOI) that demonstrated a significant (p = 0.01) change in expression following T9 
axotomy, as determined by a 2-factor ANOVA. 3.1, Genes known to be associated with axonal regeneration, cell survival and neuroprotection. 
These gene lists are arraigned in alphabetical order and include both the symbol and full gene name. Also included in this table are a series 
of references used to classify these genes into their specific category.Siebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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Figure 4 Expression profiles of specific genes classes significantly altered following spinal transection. The expression profiles illustrate the 
normalized log2 expression values with low expression values being represented by green and high expression in red. The three expression profiles 
illustrated here were generated using a combination 2-factor ANVOA with a significance of (p = 0.01, based on 1000 permutations) and cluster analysis 
to reveal the expression patterns. A, Expression profiles for 14 of the 84 genes associated with regeneration (RAG) or cell survival and neuroprotection 
(CsNp) using the ANOVA analysis demonstrated a significant change in expression following injury. As shown, all were upregulated. B, The expression 
profile for genes associated with surface receptors, neurotrophic receptors, and neurotrophins and growth factors (GF). ANOVA analysis revealed 8 of 
the 214 genes examined exhibited a significant change in expression following the injury, 3 of which (Unc5a, Lingo1, Fgf9) are down-regulated. C, 
Even though both pro- and anti-apoptotic genes were included, all seven genes revealed by this analysis are pro-apoptotic. Only one of the seven 
genes is down regulated (Siva1), while the other 6 demonstrate a sharp up-regulation following axotomy. A, B, C All three-expression profiles have a 
common pattern in gene expression that matches the pattern found for the overall significant response (see Figure 2). Asterisk indicates genes from 
the genome wide hypothesis free analysis also identified in our specific gene programs. Plus sign indicates genes whose expression values were val-
idated by qRT-PCR. Black circle indicates genes validated immunofluorescently.Siebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
Page 13 of 23
of our samples. It is also possible that alternative splicing
may have occurred, which could have yielded different
results because the array data interrogated the entire
mRNA, while real time qPCR only amplifies a very small
segment (usually one exon).
Immunofluorescent validation of the TPS neuronal 
response to injury
Our previous work indicates that most TPS axons are
severely damaged by low thoracic (T9) spinal contusion
injury [30]. To confirm that the observed changes in gene
expression in the transection model are an accurate por-
trayal of the TPS neuronal response to contusion injury,
the expression of 8 different proteins (Gap43, Hspb1,
Gfra1, Ret, Casp3, Ntrk1, Ntrk2, and Ntrk3) were exam-
ined immunofluorescently in DTMR retrogradely labeled
TPS neurons following a moderate spinal contusion
injury (NYU Impactor; 25 mm, 10 g weight drop). Com-
parisons were made at the 1-week post-injury time point
in order to minimize confounding results due to lesion
site debris-induced autofluorescence apparent at 3 days
p.i.. Immunofluorescent analysis of the response of TPS
neurons to a T9 contusion injury (Figure 6), mirrors the
expression pattern revealed by gene array one week post-
transection. Hspb1 immuno-labeling was evident in the
majority of DTMR labelled cells 1-week post-contusion
(Figure 6A-C). Gap43 immunoreactivity was only appar-
ent in a small percentage of the DTMR labeled neurons 1-
week p.i. (Figure 6F), being colocalized in one of the two
DTMR labeled TPS neurons shown. However, axonal
immuno-labeling with Gap43 was apparent throughout
the intermediate gray matter. Activated Caspase3
Table 5: Specific Surface Receptor and Neurotrophic Factor Genes of Interest Exhibiting Significant Change in Expression 
Post-Injury
Gene Name Symbol(s) Reference
Fibroblast growth factor 9 Fgf9 [25]
GDNF family receptor alpha 1 Gfra1 [22,97-99]
Insulin-like growth factor 1 Igf1 [2,23,24]
Leukemia inhibitory factor receptor Lifr [23]
Leucine rich repeat and Ig domain containing 1 Lingo1 [26,27,29,53,100,101]
Neural cell adhesion molecule 1 Ncam [22,23,99,102]
Ret proto-oncogene Ret [22,97,98]
Unc-5 homolog A Unc5a [28,55,103]
Specific genes from our complied lists of genes of interest (GOI) that demonstrated a significant (p = 0.01) change in expression following T9 
axotomy, as determined by a 2-factor ANOVA. Genes specific to surface receptors, growth factor, and neurotrophic agents. These gene lists 
are arraigned in alphabetical order and include both the symbol and full gene name. Also included in this table are a series of references used 
to classify these genes into their specific category.
Table 6: Apoptotic genes of interest exhibiting significant change in expression post-injury
Gene Name Symbol(s) Reference
BRCA1 associated RING domain 1 Bard1 [104]
BCL2-associated × protein Bax [105,106]
Caspase 3 Casp3 [23,105,107,108]
Death-associated protein Dap [109,110]
Growth arrest and DNA-damage-inducible 45 gamma Gadd45g [111]
PYD and CARD domain-containing protein Pycard, Asc [112,113]
SIVA1, apoptosis-inducing factor Siva1 [114]
Specific genes from our complied lists of genes of interest (GOI) that demonstrated a significant (p = 0.01) change in expression following T9 
axotomy, as determined by a 2-factor ANOVA. Genes associated with the process of apoptosis. These gene lists are arraigned in alphabetical 
order and include both the symbol and full gene name. Also included in this table are a series of references used to classify these genes into 
their specific category.Siebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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Figure 5 PCR validation of gene expression data. A, The log2 difference was obtained to give the direction of change in the expression values. B, 
P values for the significance in change of expression were determined using a two-tailed student t-test, for each time point comparison. A, B, Values 
appearing both bolded and italicized are genes demonstrating a significant change in expression (P-value). F, A correlation analysis between the log2 
differences of expression in gene array and PCR array was run to see if the expression trends observed in the gene array data corroborated the expres-
sion trends displayed in the PCR array. The overall correlation of 0.69 reveals a reasonable. C, D, E, The top three correlated genes (Hspb1, Gfra1, Gfra2) 
are plotted to illustrate the correlated expression trends between the log2 differences of the gene array data and PCR data. G, Summary of the data 
presented in panels A, B and F. Genes demonstrating a significant and correlated change in expression following injury in both the gene and PCR 
arrays are indicated in red (Actb, Fgf9, Gfra1, Hspb1). Genes with a significant change in expression in either the gene array or PCR array and demon-
strate correlated expression trends are indicated in pink. Time points where no significant change in expression was found, but a correlation of ex-
pression between the two arrays is found are indicated in purple, The one time point where a significance in change of expression is found but the 
expression trends diverge is indicated in black.Siebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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immuno-labeling (Figure 6V-X) was also found in a pro-
portion of the DTMR labeled TPS neurons (Figure 6X) at
this time-point. There was extensive double labeling of
DTMR retrogradely labeled TPS neurons 1-week post-
contusion with either Gfra1 or Ret (Figure 6I,L). The
majority of DTMR labeled TPS neurons were also
immuno-labeled by Gfra1 or Ret in uninjured control
sections indicating that these receptors are normally
present in TPS neurons. Because our tissue sections were
not stringently controlled to allow a quantitative analysis,
we were unable to determine if the amount of immuno-
labeling was increased post-contusion.
No significant change in the expression of the neu-
rotrophic factor receptors Ntk1 (Trk A), Ntk2 (Trk B) or
Ntrk3 (Trk C) was seen in the microarray or PCR array
analyses. However, these three Trk receptors were
included in our immuno-labeling analysis because of the
key role they play in mediating the effect of neurotrophic
factors (NGF, BDNF, and NT-3, respectively) on cell sur-
vival and axonal growth [4,31,32]. Immuno-labeling for
Ntrk1 (Trk A) Ntrk2 (Trk B), and Ntrk3 (Trk C) (Figure
5N,Q,T) colocalized (Figure 6O,R,U) in many DTMR
labeled TPS neurons (Figure 5M,P,S). However when the
post-axotomy staining was compared to non-injured con-
trols (data not shown) no noticeable difference in the
amount of immuno-labeling within individual TPS neu-
rons or the relative number of TPS neurons that were
immuno-labeled by each neurotrophin receptor antibody
was observed (data not shown).
Discussion
Microarray technology has been used previously to
examine the early genetic response following SCI
[15,24,33-36]. However, most investigations studied the
lesion site and/or nearby damaged spinal cord in its
entirety and focused mainly on the acute or sub-acute
period, ranging from a few hours to several days, and did
not follow changes in gene expression over time [37].
Studies examining genetic changes of long tract neurons
post-SCI, such as the corticospinal tract, usually have
used in situ hybridization. This method is able to resolve
genetic changes at a cellular level but is able to analyze
only a small number of selected genes [7,38].
The present study expands on previous studies in sev-
eral important ways. First, we used LMD to specifically
collect individual FG retrogradely prelabeled TPS neu-
rons at different times after axotomy. Additionally, our
use of the Affymetrix Rat 1.0 Gene ST Array allowed us
to examine the post-injury changes that occurred within
the entire Rattus norvegicus genome. Finally, rather than
focusing on the acute injury response during the first 24
hours after SCI, our analysis began 3-days post injury
(p.i.), and continued until 1-month p.i., a longer period
than analyzed in most previous studies.
One potential criticism of using FG to prelabel TPS
neurons is that FG may have cytotoxic effects on retro-
gradely labeled neurons over time [39,40]. Therefore, we
used separate control groups with similar post-FG injec-
tion survival times to compare at each interval examined
post-SCI. Little difference was found comparing these
control groups with each other in our microarray analysis
and no evidence of a pro-apoptotic response was
detected, further eliminating this potential variable from
confounding our findings.
The microarray gene expression data for 14 genes of
interest was validated using a combination of qRT-PCR
and/or immunohistochemistry (IHC). While the spinal
transection model was utilized for the microarray expres-
sion data to ensure all harvested FG labeled neurons were
axotomized, we used a spinal contusion injury model for
IHC validation. This second model also axotomizes most
TPS neurons [30], but results in greater secondary injury
processes and continued injury expansion p.i. than spinal
transection [41,42]. Additionally, spinal contusion injury
accounts for most spinal cord injuries in human beings
(SCI network).
One limitation of the present study is that because of
the complex experimental design, large numbers of dif-
ferent groups compared, and small numbers of samples
per group (N = 4), the FDR correction we applied to iden-
tify genes exhibiting significant main effects of the SCI in
the hypothesis-free genome-wide analysis is likely to be
overly stringent, since many genes clearly showed
changes at only one or two of the time points examined.
Evidence of this was obtained by the qRT-PCR validation,
which revealed three additional genes (Gfra2, Ngfrap1,
and Npy) exhibiting significant changes in gene expres-
sion that only achieved nominal significance in the
microarray analysis. To circumvent this problem, we spe-
cifically designed three gene lists that we hypothesized
would be critically involved in the response to injury
(RAG and CsNp genes, GF genes, and Apoptosis Genes)
determining significance at each time point by perform-
ing a 2-factor ANOVA, (treatment × time), with a P value
cutoff of 0.01 based on 1000 permutations. The hyper-
geometric analysis of these data indicated a highly signifi-
cant 4.1 fold enrichment of RAG/CsNp genes suggesting
an integrated gene network of genes involved in regener-
ation and neuroprotection. Such a network effect was not
found for the other two gene lists analyzed, but a small
group of upregulated pro-apoptotic genes, and growth
factor receptor genes was revealed by this analysis. Addi-
tionally, we used IPA analysis for evidence of enrichment
of significantly changed genes in specific biological path-
ways/gene networks. To gain a broader view of the
genetic response, the data uploaded to IPA consisted of
all the genes significantly changed at a P value of 0.05 or
less after FDR correction, and further filtered so onlySiebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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Figure 6 Immunofluorescent analysis of the TPS neuronal response to a low thoracic contusion injury 1-week post-injury. A, D, G, J, M, P, S, 
V, TPS neurons were retrogradely labeled by bilateral injections into the intermediate gray matter of the upper lumbosacral enlargement with DTMR 
4 days prior to the injury, and 1-week following injury in cryostat sections (Cy3 Filter). B, E, H, K, N, Q, T, W, These sections also were immunolabeled 
by 1 of 8 antibodies. Examples show immuno-labeling within thoracic neurons (FITC Filter) related to cell survival, Hspb1; regeneration, Gap43; growth 
factor receptors, Gfra1, Ret, Ntrk1, Ntrk2, Ntrk3; and apoptosis, Casp3. C, F, I, L, O, R, U, X, TPS neurons colocalizing with the immuno-label for all 8 
proteins are shown in these merged images. Y, Cartoons show the region of the intermediate gray matter from which the digital images were taken. 
All images taken at 40x; Scale bars = 100 μm.Siebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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genes expressed in the nervous or immune systems would
be analyzed (see Materials and Methods for detailed
information).
TPS neurons mount an early but transient regenerative 
response post-axotomy
One factor previously shown to be important in the cell
body response to axotomy is the distance between the
location of the axotomy and the neuron's cell body. In this
study, the neurons analyzed were collected from the T6-
T7 spinal segment, two segments rostral (approximately 2
mm) from the lesion site. Besides the axotomy being close
to the cell body, TPS neurons are located near the lesion
site with the associated inflammatory and immune
responses that occur in this region. Both of these factors
are likely to play a role in the regenerative response of
TPS neurons (see below).
Our microarray expression data and qRT-PCR experi-
ments confirm that TPS neurons mount a robust regen-
erative response 3-days p.i. Genes demonstrating a
significant up-regulation following injury at the p < 0.01
level include a group of genes classically associated with
axonal regeneration (RAGs) including: Jun, Atf-3, Hspb1
(HSP-27), Adcyap1, Gadd45a, Gap43, Actb, and Tubb3. If
this level of significance is changed to p < 0.05, an addi-
tional gene associated with axonal regeneration, Stmn2
(SCG-10), achieves significance. These genes are among
those up-regulated within PNS neurons during regenera-
tion following a peripheral nerve injury [43], up-regu-
lated within CNS neurons after axotomy close to the cell
body [7,8,44], and up-regulated within CNS neurons hav-
ing axons regenerating into peripheral nerve grafts [7].
However, unlike the PNS where these RAGs remain up-
regulated until regenerating axons reach their peripheral
target, all of these genes are down-regulated rapidly by 1-
week p.i., and approach control levels at longer survival
times. This early transient but abortive regenerative
response has been reported for particular classes of neu-
rons within the CNS [45-47]. An early regenerative
response in corticospinal tract (CST) neurons is seen
after axotomy near the cell body, but is not seen after spi-
nal axotomy [8]. An early regenerative response is also
seen within rubrospinal tract (RST) neurons after cervi-
cal, but not after thoracic axotomy [7]. This difference in
the regenerative response is likely the reason RST axons
will regenerate within peripheral nerve grafts implanted
into the cervical, but not thoracic spinal cord. While
there is a large body of supportive evidence that axotomy
near the cell body is a key factor in eliciting a regenerative
response, there are also exceptions such as Purkinje cells
[48]. 2005). The reasons for this difference are unknown
except for the possibility that the recurrent collaterals of
Purkinje cells are "sustaining", minimizing a cellular reac-
tion [49]. The local axotomy that occurs in TPS neurons
after thoracic SCI is a likely reason for the early robust
regenerative response found in the present study. This
early regenerative response is also likely to be the reason
propriospinal axons are better than supraspinal axons in
their ability to grow within peripheral nerve or Schwann
cell grafts implanted within the spinal cord [9-13]. It is
presently unknown if factors in these grafts maintain the
cellular response, and/or factors within the CNS environ-
ment inhibit it. Schwann cells and vascular macrophages
within peripheral nerve grafts secrete a variety of neu-
rotrophic and growth factors as well as extracellular
matrix molecules that are both neuroprotective and sup-
port continued axonal growth [50]. The factors present in
the post-injury spinal cord environment that inhibit
axonal regrowth have been extensively reviewed [1,2] and
will not be discussed here, but include chondroitin sulfate
proteoglycans (CSPGs) and myelin debris, among others.
A recent study conducted by Fenrich and Rose [51]
found that, following a focal midline sagittal surgical
injury, local propriospinal commissural (PCI) axons
regenerate across the lesion site forming specific synaptic
connections with contralateral motoneurons. Unlike the
present study, PCI neurons did not appear to undergo
apoptosis following this injury (see section 3, below). The
authors hypothesize that PCI axons are able to respond to
guidance molecules in a way that allows them to cross the
midline and grow through the CSPG rich lesion site. The
findings from the present study, demonstrating a signifi-
cant down-regulation in the gene for Unc5a, a receptor
which mediates the chemorepulsive effect of netrin-1
during development [52], could be related to the success
of regrowth, as could the down-regulation of both Lingo1
[27,53] and Ngfrap1[54], receptors that mediate inhibi-
tory cues from the post-injury environment. Previous
studies demonstrate that antagonizing Lingo1 or Unc5a,
enhances axonal regeneration in the post-lesion environ-
ment [27,28,53,55].
Besides the transient up-regulation of RAGs 3-days
post-SCI, the largest changes found for most classes of
genes occurred during this early period including genes
related to the immune and inflammatory response, cell
survival, and cell death. Again, these changes returned
towards pre-axotomy levels at longer survival times. In
the sections below we discuss how (if) the abortive regen-
erative response of TPS neurons may be related to the
timing and transient nature of the immune/inflammatory
reaction, or to the apparent cell death of most TPS neu-
rons.
Early Inflammatory Response
The present investigation did not examine the genetic
response of axotomized TPS neurons during the first 48-
hours post p.i. or the early response to pro-inflammatory
cytokines which has been described by others following
traumatic spinal injury [15]. The genome-wide analysisSiebert et al. BMC Neuroscience 2010, 11:69
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performed in the present study identified a large number
of highly up-regulated genes related to the immune/
inflammatory response or cell stress/neuroprotection at
the earliest time point, 3-days p.i (Figure. 2, Table 2). The
IPA results also showed the three main pathways/net-
works significantly changed in TPS neurons at this time
were related to the inflammatory/immune-response,
which was not the case at later periods (Additional File 2;
Supplement Table 5). The inflammatory/immune
response genes most highly up-regulated at 3-days p.i.
returned towards normal by 1-week post-SCI, just as seen
for the RAGs.
It is possible that the early robust immune/inflamma-
tory response we observed in our analysis was caused by
immune cell contamination acquired during the laser
microdissection. Microglial/macrophage contamination
cannot be completely excluded since genes expressed by
these cells such as Itgam (Integrin alpha M), a.k.a, Cr3 or
Cd11b http://www.genecards.org/cgi-bin/carddisp.pl?
gene=ITGAM, appeared in our analysis. However, a sig-
nificant number of contaminating immune cells would
have resulted in the up-regulation of several other genes/
markers for microglia or macrophages (i.e., Cd163, or
Aif1) that was not seen. Furthering our belief that the
mRNA collected was from a relatively pure sample of TPS
neurons was the lack of expression for Gfap (a marker for
astrocytes) and the myelin proteins Mag, Mog, Mbp
(markers for both oligodendrocytes and myelin debris).
Thus, our data suggests specificity at a cellular rather
than a tissue level, indicating mainly intra-neuronal TPS
genes have been analyzed.
There is strong evidence that indicates the inflamma-
tory response exacerbates damage at the injury site and
contributes to the lack of axonal regeneration, as well as
to neuronal apoptosis at the lesion site [15,56]. Therefore,
inflammation early post-SCI may be a contributing factor
in potential TPS apoptosis (see below). However, other
evidence indicates that the inflammatory response and
invasion of vascular macrophages [6,38,57-62] may be
neuroprotective, as well as stimulating a maximal regen-
erative response [61,62], and can foster successful regen-
eration within PNS implants [45-47] or within the CNS,
itself [38]. For instance, an inflammatory reaction near
their cell bodies increases the expression of RAGs in CST
neurons although this response does not contribute to
the sprouting or regeneration of CST axons damaged in
the spinal cord [38]. In this instance, it would be interest-
ing to see if the damaged CST axons would now be able to
regenerate within a peripheral nerve implant. Similarly,
retinal ganglion cell axons grow poorly within PNS grafts
unless the axons are damaged close to the optic disc, near
their cell bodies of origin [63], but regenerate most suc-
cessfully within peripheral nerve grafts and the optic
nerve, itself, with the addition of an inflammatory
response resulting from lens injury or other perturbation
[58,60]. These studies argue for a component of the
inflammatory response playing a major role in the ability
of CNS neurons to mount a regenerative response, and
may be one reason why injury (axotomy) near the cell
body, as in the present case, elicits a regenerative
response. Recent evidence suggests that the type of mac-
rophage that may be neuroprotective and supports
axonal regeneration is found mainly during the first few
days following SCI, and the type of macrophage detri-
mental to this process is found chronically after SCI [64].
Whether this difference in the inflammatory response is
responsible for the time course of the TPS regenerative
response remains to be determined.
3. Post-axotomy cell death of axotomized TPS neurons?
Preliminary results from our laboratory [17] show a large
loss in the number of labeled TPS neurons by 2-weeks p.i.
as assessed by first retrogradely pre-labeling these neu-
rons with FG from the lumbosacral enlargement prior to
moderate spinal contusion injury. Cell counts 2-weeks p.i.
are approximately 70% lower than in uninjured controls.
To determine if our retrograde findings were related to
cell death, we studied both pro- and anti-apoptotic genes
post-SCI in the present analysis. We found a significant
up-regulation in gene expression for a number of pro-
apoptotic genes including Casp3 (validated with IHC)
and no significant change in expression for any anti-
apoptotic genes indicating that significant apoptosis is
likely to occur post-axotomy. IPA analysis also indicated
an early up-regulation of a number of genes involved in
apoptosis that returned to control level, or were down-
regulated at later time points. The question remains as to
whether this change in genetic response of TPS neurons
apparent at the end of the first post-operative week
resulted from the inability of TPS axons to regenerate in
the post-injury spinal environment, or is due to the post-
SCI cell death of the majority of axotomized TPS neu-
rons. It may be that the surviving TPS neurons sampled at
later survival times are a different population, for
instance cells with sustaining collaterals that could limit
regeneration and be more resistant to apoptosis.
Again, as with the inflammatory response, the maximal
response of RAGs and CsNp genes overlapped with the
early up-regulation of pro-apoptotic genes. Others have
also reported a parallel increase in a regenerative
response post-axotomy, such as an upregulation of Gap43
and an up-regulation of genes involved in apoptosis, usu-
ally when axotomy is close to the cell body, and where
most axotomized neurons subsequently undergo cell
death [65-67]. The post-axotomy apoptosis of neurons in
these instances has been prevented or delayed by provid-
ing appropriate trophic support [11,12], by placing the
damaged axons in an environment that supports/permitsSiebert et al. BMC Neuroscience 2010, 11:69
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axonal regeneration [10,13], or by blocking the apoptotic
response [65-67]. Classes of neuron such as the Purkinje
cell of the cerebellum normally do not have a regenerative
response even with axotomy close to the cell body, and
are resistant to post-axotomy cell death [48]. However, in
transgenic mice where Gap43 is overexpressed in
Purkinje cells, even though axonal sprouting occurs, axo-
tomy leads to cell loss unless these neurons are protected
by factors in embryonic grafts placed near the severed
axons, as reviewed in [48]. However, in this and other
cases [48], even when apoptosis is prevented, significant
axonal regeneration does not take place without addi-
tional interventions.
Therapeutic Implications for TPS Neurons
The robust regenerative response of TPS neurons after
thoracic SCI is different than that found for most
supraspinal neurons (e.g. CST, RST). However, the appar-
ent cell death of the majority of TPS neurons early after
thoracic SCI as well as the transient nature of the regen-
erative response is also different from that found for most
supraspinal neurons (CST, RST) where neuronal atrophy
results, and cell loss occurs slowly, if at all [68-70]. Previ-
ous evidence indicates that propriospinal axons have an
advantage over supraspinal axons in their ability to regen-
erate after SCI [4,11,31,32]. In all of these instances, the
affected propriospinal neurons were close to the site of
injury, and regenerated into environments conducive to
regrowth such as peripheral nerve implants or other type
of implant that contained trophic molecules likely to be
neuroprotective as well as maintaining the regenerative
response. Our findings are most similar to the effects of
optic nerve damage near the retina, and the consequent
early regenerative and cell death response of the majority
of retinal ganglion cells (RGCs). It is possible that treat-
ments enhancing RGC survival and axonal regeneration
will also be effective for TPS neurons (potentially includ-
ing PS neurons locally axotomized by SCI at other spinal
levels) including the effects of lens injury that increase
RGC survival and axonal regeneration after optic nerve
injury [58,60]. Our result indicates that intervention
needs to be rapid, within a few days, prior to apoptosis,
just as for RGCs. In addition, presenting TPS neurons
with specific macrophage related factors may also be ben-
eficial to maintaining axonal regeneration within a CNS
environment [64].
To determine the neurotrophic or growth factor(s) that
would be most effective in protecting TPS neurons from
apoptosis, and could potentially maintain the initial
regenerative response, we analyzed surface receptor and
growth factor expression profiles (Figure 4B). We found
the simultaneous up-regulation of both co-receptor genes
for the neurotrophic factor GDNF (Gfra1 and Ret). Ian-
notti and colleagues [12] have shown that GDNF
enhances axonal growth within implants, and, using
intrathecal application to the SCI lesion site, is neuropro-
tective for TPS neurons and several classes of supraspinal
neuron post-SCI. In our analysis we also found an upreg-
ulation in Lifr, a receptor for LIF and a co-receptor for
CNTF. Recently, it was demonstrated that LIF and CNTF
are important growth factors caused by lens damage that
protect RGCs and stimulate axonal regeneration after
optic nerve injury [71]. Other data also suggest that LIF
and CNTF might be effective neuroprotective agents for
TPS neurons and maintain axonal regeneration after SCI
[72-74]. In our analysis we found no significant change in
the expression of the Trk receptors for the neurotrophins
post-axotomy (NGF, nerve growth factor, Ntrk1 (Trk A);
BDNF, brain derived neurotrophic factor, Ntrk2 (Trk B);
or NT-3, Ntrk3 (TrkC)). However, the majority of TPS
neurons continued to be immunolabeled by appropriate
antibodies, suggesting that TPS neurons are likely to
remain receptive to these neurotrophins post-SCI. These
neurotrophins have been reported to be highly neuropro-
tective and/or promote axonal sprouting/regeneration in
other classes of neuron [4,23,31,32]. Our findings suggest
that TPS neurons should be particularly sensitive to
GDNF, LIF, and CNTF during the first week p.i., and
these are the growth factors most likely to be effective in
protecting TPS neurons from apoptosis and maintaining
a regenerative response within a CNS environment.
There is also evidence these molecules as well as neu-
rotrophins may need to be used in combination acting
synergistically on different intracellular targets for a max-
imal neuroprotective/regenerative response [75].
Conclusion
Previous studies have demonstrated the ability of PS
axons to grow into peripheral nerve implants and neu-
rotrophin enriched bridges, form functional new neu-
ronal bypass circuits around an incomplete lesion, and
cross the midline to form new circuits [11,12,47-49]. Our
microarray, qRT-PCR, and immunofluoresence data
show that TPS neurons respond to axotomy and low tho-
racic SCI with an early strong inflammatory response and
a robust but transient neuroprotective/regenerative
response that diminish by the end of the first week p.i., as
well as a strong apoptotic response that appears to lead to
the loss of the majority of these neurons by 2-weeks p.i..
Early changes in TPS neurons return to near normal lev-
els of expression in 2-week and 4-week samples, suggest-
ing that the surviving TPS neurons sampled at these time
points could be a different population, potentially cells
with sustaining collaterals that limit the effects of axo-
tomy. Up-regulation of receptors to several growth fac-
tors suggest reasons why TPS neurons survive and
regenerate within peripheral nerve implants. These spe-
cific growth factors could be applied singly or together inSiebert et al. BMC Neuroscience 2010, 11:69
http://www.biomedcentral.com/1471-2202/11/69
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future experiments attempting to protect axotomized PS
neurons from apoptosis and maintain the regenerative
response after spinal cord injury.
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